Other studies showed that overexpression of SKA1 and SKA3 was related to cancer aggressiveness in several other cancers, including non-small cell lung cancer, prostate cancer, bladder cancer, gastric cancer, colorectal cancer and adenoid cystic carcinoma [35–40]. Here, SKA1 is linked to prostate cancer.